This finding suggests that there might be similar druggable dependencies between CCNK/CDK12 or CCNK/CDK13 complexes and the cancer types included in the GDSC1 dataset such as BRCA and AML. This evidence concerns the gene CDK13 and acute myeloid leukemia.